NDC 17856-1045-2 - Nystatin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1045
- Requested NDC
- 17856-1045-2
- Package NDCs from labels
- 17856-1045-2, 17856-1045-1, 17856-1045-4, 17856-1045-3, 17856-1045-6, 17856-1045-5, 17856-1045-8, 17856-1045-7, 17856-1045-9
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-05-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nystatin Oral Suspension USP [100,000 units per mL] | ATLANTIC BIOLOGICALS CORP. | 2025-05-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1045-1 | Nystatin | 72 in 1 BOX, UNIT-DOSE | SUSPENSION | 72 | 3 | |
| 17856-1045-2 | Nystatin | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 3 | |
| 17856-1045-3 | Nystatin | 48 in 1 BOX, UNIT-DOSE | SUSPENSION | 48 | 3 | |
| 17856-1045-4 | Nystatin | 5 mL in 1 SYRINGE | SUSPENSION | 5 | 3 | |
| 17856-1045-5 | Nystatin | 48 in 1 BOX, UNIT-DOSE | SUSPENSION | 48 | 3 | |
| 17856-1045-6 | Nystatin | 5 mL in 1 SYRINGE | SUSPENSION | 5 | 3 | |
| 17856-1045-7 | Nystatin | 120 in 1 BOX, UNIT-DOSE | SUSPENSION | 120 | 3 | |
| 17856-1045-8 | Nystatin | 1 mL in 1 SYRINGE | SUSPENSION | 1 | 3 | |
| 17856-1045-9 | Nystatin | 5 mL in 1 SYRINGE | SUSPENSION | 5 | 3 | |
| 17856-1045-9 | Nystatin | 1 in 1 BAG | SUSPENSION | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1045 | NYSTATIN SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 3 | 10 package rows | 20250524_2e7fadda-5f16-4be6-b6bb-985fafe3a1f3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1045-1 | ML - Milliliter | 17856-1045 | 67a16705-3c65-4aa4-8a0a-1e38af699cf1 | 1 | 2024-09-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Peacefuli | AVENA SATIVA, HUMULUS LUPULUS, PASSIFLORA INCARNATA, KALI PHOSPHORICUM, ANACARDIUM ORIENTALE, ARGENTUM NITRICUM, IGNATIA AMARA | Ratis, LLC | eb3bc662-3d3d-4e4d-8561-330ad0eb08f2 | 2023-05-25 | Warnings | CI71S98N1Z |
| Bacteriostatic Water | WATER | Medical Purchasing Solutions, LLC | 69485218-9343-952d-e053-2a91aa0ad4e8 | 2023-05-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | STERILE WATER | Hikma Pharmaceuticals USA Inc. | b20a28b0-7dfa-42eb-9177-ec256d5a5ef7 | 2023-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Pain Relief | DIBASIC POTASSIUM PHOSPHATE,HYPERICUM PERFORATUM,TOXICODENDRON PUBESCENS LEAF,BRYONIA ALBA ROOT AND MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | Hyland's Inc. | a57ac701-c42d-6b2f-e053-2995a90a112d | 2023-05-08 | Warnings | CI71S98N1Z |
| Kali phosphoricum | DIBASIC POTASSIUM PHOSPHATE | Boiron | 8609d979-1e48-4152-e053-2991aa0a11a2 | 2023-04-11 | CI71S98N1Z | |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Virility Liquescence | AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA | Nutritional Specialties, Inc. | 81cc3e2b-f95e-4ba4-a15f-c07b4def0e2f | 2023-03-29 | Warnings | PDC6A3C0OX |
| Kali phosphoricum | DIBASIC POTASSIUM PHOSPHATE | Boiron | 8609b2fe-c962-24aa-e053-2a91aa0a8288 | 2023-03-27 | CI71S98N1Z | |
| Kali phosphoricum | POTASSIUM PHOSPHATE, DIBASIC | Laboratoires Boiron | 937f07e0-7be2-11e6-ae5d-424c58303031 | 2023-03-09 | Warnings | CI71S98N1Z |
| Kali Phosphoricum | KALI PHOSPHORICUM | Hahnemann Laboratories, INC. | f66e6f3f-4999-e60f-e053-2995a90ae5e0 | 2023-03-08 | CI71S98N1Z | |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 53d1c23b-9cf2-4941-8701-8a7da1b066cc | 2023-03-03 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 84383bc5-1282-43d6-9303-23c8fd8d075f | 2023-03-03 | Adverse reactions | BDF1O1C72E |
| NYSTATIN AND TRIAMCINOLONE ACETONIDE | NYSTATIN, TRIAMCINOLONE ACETONIDE | Padagis Israel Pharmaceuticals Ltd | 92fc188d-4f3e-4d18-aaf1-c9e76b12b75b | 2023-03-01 | Adverse reactions | BDF1O1C72E |
| nystatin and triamcinolone acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Padagis Israel Pharmaceuticals Ltd | 605540d8-7189-49b9-9e91-572f6b519fae | 2023-03-01 | Adverse reactions | BDF1O1C72E |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Saccharum officinale | SUCROSE | Boiron | 6858f374-8549-4b00-e053-2991aa0a5c3c | 2023-02-20 | C151H8M554 | |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | XF417D3PSL |
| Nystatin | NYSTATIN | A-S Medication Solutions | e069d495-7f1a-4970-8f4d-aa93d124b3fc | 2023-02-04 | Adverse reactions | 312055 BDF1O1C72E |
| Saccharum Officinale | SACCHARUM OFFICINALE | Hahnemann Laboratories, INC. | f04b0ab3-af1c-ec2d-e053-2995a90a7855 | 2023-01-27 | C151H8M554 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.